000 person-years during the post-PCV period (P=.36)." 4 Similar results were seen in a 1995 to 2003 study, where rates fell 68%, from 1.7 infections per 100 person-years (1995-2000) to 0.5 infections per 100 person-years (2001-2002). 5 Before vaccines, infection was the leading cause of death in pediatric sickle cell patients (33%-48%). 6 Now, vaccine compliance is essential to prevent illness and death from infectious diseases in SCD. In this article, we investigate the status of immunizations among children with sickle cell disease in Louisiana, and we compare their rates to the general population. We discuss differences in these rates within the New Orleans metropolitan area and compare them with previously reported findings in Michigan.
MethodsImmunization records of children with sickle cell anemia from the LINKS system and at the Louisiana Department of Health from 1997 to 2018 were reviewed. The data in the LINKS system is collected as part of a state-mandated newborn screening program. Any child born in Louisiana undergoes neonatal screening for multiple pathologies, including Hemoglobin defects. Those found to have Sickle Cell Disease are referred to Pediatrics and Hematology physicians, and they are followed in a state registry.In this review, 4 parishes in the New Orleans metro area were selected to study the variability of vaccination rates between diverse populations within the same region.Immunization guidelines were taken from the Centers for Disease Control and Prevention (CDC).
ResultsAccording to the Louisiana Dept of Health, 86.6% of children with sickle cell anemia were vaccinated against Hepatitis B, which is standardly the first vaccine to be administered to children. Of routine 2-month vaccinations, DTaP and Hib were administered to 97.1% and 94% of children with SCD, respectively. After 2009,